Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets
Devin B. Lowe, Camille K. Bivens, Alexis S Mobley, et al.
mAbs (2017) Vol. 9, Iss. 4, pp. 603-614
Open Access | Times Cited: 25

Showing 25 citing articles:

Bispecific antibodies targeting mutantRASneoantigens
Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J. Mog, et al.
Science Immunology (2021) Vol. 6, Iss. 57
Open Access | Times Cited: 133
The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads
Valentina Boni, Manish Sharma, Amita Patnaik
American Society of Clinical Oncology Educational Book (2020), Iss. 40, pp. e58-e74
Open Access | Times Cited: 57
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
Xin Liu, Yixiang Xu, Wei Xiong, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e004035-e004035
Open Access | Times Cited: 32
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Christina Chen, Xin Liu, Che‐Yu Chang, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1008-1008
Open Access | Times Cited: 19
Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants
Lauren Stopfer, Aaron S. Gajadhar, Bhavin Patel, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 37
Open Access | Times Cited: 38
Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen
Lionel Low, Angeline Goh, J K Koh, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 37
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas
Lauren Stopfer, Nicholas J. Rettko, Owen Leddy, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 49
Open Access | Times Cited: 20
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
Gabriele Antonarelli, Federica Giugliano, Chiara Corti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 884-884
Open Access | Times Cited: 27
Detection of specific antibody-ligand interactions with a self-induced back-action actuated nanopore electrophoresis sensor
Sai Santosh Sasank Peri, Manoj K. Sabnani, Muhammad Usman Raza, et al.
Nanotechnology (2019) Vol. 31, Iss. 8, pp. 085502-085502
Closed Access | Times Cited: 24
1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs
Lauren Stopfer, Alicia D. D’Souza, Forest M. White
Immuno-Oncology Technology (2021) Vol. 11, pp. 100042-100042
Open Access | Times Cited: 20
Nanobody-based CAR T cells targeting intracellular tumor antigens
Haixia Li, Dani Zhong, Huiguan Luo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113919-113919
Open Access | Times Cited: 13
Opportunities and Challenges for Antibodies against Intracellular Antigens
Xiaofeng Yang, Shenxia Xie, Xiaomei Yang, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7792-7806
Open Access | Times Cited: 17
The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein
Ying Shen, Yiming Li, Jingjing Zhou, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3912-3912
Open Access | Times Cited: 13
Modeling antibody drug conjugate potential using a granzyme B antibody fusion protein
Trevor S. Anderson, Amanda L. McCormick, Savanna L. Smith, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Validation and quantification of peptide antigens presented on MHCs using SureQuant
Owen Leddy, Yufei Cui, Ryuhjin Ahn, et al.
Nature Protocols (2024)
Closed Access | Times Cited: 1
TCR mimic compounds for pHLA targeting with high potency modalities in oncology
Hans‐Peter Gerber, Leonard G. Presta
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Antibody-drug conjugates: an evolving approach for melanoma treatment
Trevor S. Anderson, Amanda L. Wooster, Ninh M. La‐Beck, et al.
Melanoma Research (2020) Vol. 31, Iss. 1, pp. 1-17
Closed Access | Times Cited: 7
Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01
Se-Young Lee, Deok‐Han Ko, Min-Jeong Son, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2349-2349
Open Access | Times Cited: 7
Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptors
William J. McDaid, Nikolai M. Lissin, Ellen Pollheimer, et al.
Nanoscale (2021) Vol. 13, Iss. 35, pp. 15010-15020
Open Access | Times Cited: 7
Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines
Amanda L. Wooster, Trevor S. Anderson, Devin B. Lowe
Journal of Immunological Methods (2018) Vol. 464, pp. 22-30
Open Access | Times Cited: 5
The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
Sylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 9, pp. 2981-2994
Open Access | Times Cited: 5
PBMC-engrafted humanized mice models for evaluating immune-related and anticancer drug delivery systems
Yoshie Kametani, Ryoji Ito, Yoshiyuki Manabe, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Specific Inhibition of Tumor Growth by T Cell Receptor–Drug Conjugates Targeting Intracellular Cancer-Testis Antigen NY-ESO-1/LAGE-1
Chixiao Qiu, Xuefei Bai, Ying Shen, et al.
Bioconjugate Chemistry (2020) Vol. 31, Iss. 12, pp. 2767-2778
Closed Access | Times Cited: 3
Self-Induced Back-Action Actuated Nanopore Electrophoresis (SANE) Sensor for Label-Free Detection of Cancer Immunotherapy-Relevant Antibody-Ligand Interactions
Sai Santosh Sasank Peri, Muhammad Usman Raza, Manoj K. Sabnani, et al.
Methods in molecular biology (2022), pp. 343-376
Open Access | Times Cited: 2
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas
Lauren Stopfer, Nicholas J. Rettko, Owen Leddy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top